Exploring personalized neoadjuvant therapy selection strategies in breast cancer: an explainable multi-modal response model.

EClinicalMedicine · 2025 · PMC12303063 · PMID 40727014

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

did not reach statistical significanceno p-value reported

A statistically significant difference was observed for the triple-negative and ER/PR+&HER2− subtypes, while the result for HER2+ did not reach statistical significance.

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.